PerkinElmer to Acquire Antibody and Reagent Leader BioLegend

businesswire.com - PerkinElmer has entered into an agreement to acquire BioLegend, a leading, global provider of life science antibodies and reagents.

Tweeted by @Labo_Fun https://twitter.com/Labo_Fun/status/1419845900436836353